Fetal development in rhesus monkeys exposed prenatally to cocaine

Neurotoxicology and Teratology

Volumn 23, Issue 2, 2001, Pages 133-140

  Howell, Leonard L ^a,b   Schama, Kevin F ^a   Ellis, Jane E ^a   Grimley, Paul J ^a   Kitchens, Adria J ^a   Byrd, Larry D ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Physical development; Prenatal; Rhesus monkeys

Indexed keywords

COCAINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APGAR SCORE; ARTICLE; BIPARIETAL DISTANCE; BODY HEIGHT; BODY WEIGHT; COMPARATIVE STUDY; CONCEPTION; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; FETUS; FETUS DEVELOPMENT; FETUS HEART RATE; NONHUMAN; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RHESUS MONKEY; SURVIVAL RATE;

ANIMALS; APGAR SCORE; BODY WEIGHT; COCAINE; DOPAMINE UPTAKE INHIBITORS; DRUG IMPLANTS; EATING; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; FETUS; HEART; HEART RATE, FETAL; MACACA MULATTA; MALE; PREGNANCY; PREGNANCY OUTCOME; PROGESTERONE;

EID: 0035004601     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0892-0362(01)00121-0     Document Type: Article

References (45)

1. Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr. Res. Anesth. Analg. 32:1953;260-267.
2. Arpasi P., Chakraborty J. Effects of cocaine on fetal and postnatal development in mice. Life Sci. 52:1993;2063-2069.
3. Bateman D.A., Ng S.K.C., Hansen C.A., Heagarty M.C. The effects of intrauterine cocaine exposure in newborns. Am. J. Public Health. 83:1993;190-1934.
4. Benuck M., Lajtha A., Reith M.E.A. Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. J. Pharmacol. Exp. Ther. 243:1987;144-149.
5. Bingol N., Fuchs M., Diaz V., Stone R.K., Gromisch D.S. Teratogenicity of cocaine in humans. J. Pediatr. 110:1987;93-96.
6. Bourne G.H. Collected anatomical and physiological data from the rhesus monkey. Bourne G.H. The Rhesus Monkey. Anatomy and Physiology. vol. 1:1975;3-63 Academic Press, New York.
7. Chambers C.D., Griffey M.S. Use of illegal substances within the general population: The sex and age variables. Addict. Dis. 2:1975;7.
8. Chasnoff I.J. Perinatal effects of cocaine. Contemp. OB/GYN. 29:1987;163-179.
9. Chasnoff I.J., Burns W.J., Schnoll S.H., Burns K.A. Cocaine use in pregnancy. N. Engl. J. Med. 313:1985;666-669.
10. Chasnoff I.J., Lewis D.E., Griffith D.R., Willey S. Cocaine and pregnancy: Clinical and toxicological implications for the neonate. Clin. Chem. 35:1989;1276-1278.
11. Cherukuri R., Minkoff H., Feldman J., Parekh A., Glass L. A cohort study of alkaloidal cocaine ("crack") in pregnancy. Obstet. Gynecol. 72:1988;147-151.
12. Church M.W., Dintcheff B.A., Gessner P.K. Dose-dependent consequences of cocaine on pregnancy outcome in the Long-Evans rat. Neurotoxicol. Teratol. 10:1988;51-58.
13. Church M.W., Morbach C.A., Subramanian M.G. Comparative effects of prenatal cocaine, alcohol, and undernutrition on maternal/fetal toxicity and fetal body composition in the Sprague-Dawley rat with observations on strain-dependent differences. Neurotoxicol. Teratol. 17:1995;559-567.
14. Church M.W., Overbeck G.W. Prenatal cocaine exposure in the Long-Evans rat: II. Dose-dependent effects on offspring behavior. Neurotoxicol. Teratol. 12:1990;335-443.
15. Cohen H.R., Green J.R., Crombleholme W.R. Peripartum cocaine use: Estimating risk of adverse pregnancy outcome. Int. J. Gynaecol. Obstet. 35:1991;51-54.
16. Coles C.D., Platzman K.A. Behavioral development in children prenatally exposed to drugs and alcohol. Int. J. Addict. 28:1993;1393-1433.
17. Coles C.D., Platzman K.A., Smith I., James M.E., Falek A. Effects of cocaine and alcohol use in pregnancy on neonatal growth and neurobehavioral status. Neurotoxicol. Teratol. 14:1992;23-33.
18. El-Bizri H., Guest I., Varma D. Effects of cocaine on rat embryo development in vivo and in cultures. Pediatr. Res. 29:1991;187-190.
19. Forman R., Klein J., Barks J., Mehta D., Greenwald M., Einarson T., Koren G. Prevalence of fetal exposure to cocaine in Toronto, 1990-1991. Clin. Invest. Med. 17:1994;206-211.
20. Frank D.A., Zuckerman B.S., Amaro H., Aboagye K., Bauchner H., Cabral H., Fried L., Hingson R.S.D., Kayne H., Levenson S.M., Parker S., Reece H., Vinci R. Cocaine use during pregnancy: Prevalence and correlates. Pediatrics. 82:1988;888-895.
21. Gillogley K.M., Evans A.T., Hansen R.L., Samuels S.J., Batra K.K. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. Am. J. Obstet. Gynecol. 163:1990;1535-1542.
22. Hadeed A.J., Siegel S.R. Maternal cocaine use during pregnancy: Effect on newborn infant. Pediatrics. 84:1989;205-210.
23. Howell L.L. Comparative effects of caffeine and selective phosphodiesterase inhibitors on respiration and behavior in rhesus monkeys. J. Pharmacol. Exp. Ther. 266:1993;894-903.
24. Howell L.L., Morse W.H. Behavioral effects of chronically administered cocaine in squirrel monkeys. Psychopharmacology. 97:1989;12-16.
25. Hutchings D.E., Fico T.A., Dow-Edwards D.L. Prenatal cocaine: Maternal toxicity, fetal effects and locomotor activity in rat offspring. Neurotoxicol. Teratol. 11:1989;65-69.
26. Javaid J.I., Fischman M.W., Schuster C.R., Dekirmenjian H., Davis J.M. Cocaine plasma concentration: Relation to physiological and subjective effects in humans. Science. 202:1978;227-228.
27. Little B.B., Snell L.M., Klein V.R., Gilstrap L.C. III Cocaine abuse during pregnancy: Maternal and fetal implications. Obstet. Gynecol. 73:1989;157-160.
28. Lutiger B., Graham K., Einarson T.R., Koren G. Relationship between gestational cocaine use and pregnancy outcome: A meta-analysis. Teratology. 44:1991;405-414.
29. MacGregor S.N., Keith L.G., Chasnoff I.J., Rosner M.A., Chisum G.M., Shaw P., Minogue J.P. Cocaine use during pregnancy: Adverse perinatal outcome. Am. J. Obstet. Gynecol. 157:1987;686-690.
30. Mayes L.C., Granger R.H., Frank M.A., Schottenfeld R., Bornstein M.H. Neurobehavioral profiles of neonates exposed to cocaine prenatally. Pediatrics. 91:1993;778-783.
31. McCalla S., Minkoff H.L., Feldman J., Delke I., Salwin M., Valencia G., Glass L. The biologic and social consequences of perinatal cocaine use in an inner-city population: Results of an anonymous cross-sectional study. Am. J. Obstet. Gynecol. 164:1991;625-630.
32. Morris P., Binienda Z., Gillam M.P., Harkey M.R., Zhou C., Henderson G.L., Paule M.G. The effect of chronic cocaine exposure during pregnancy on maternal and infant outcomes in the rhesus monkey. Neurotoxicol. Teratol. 18:1996;147-154.
33. Morris P., Gillam M.P., Allen R.R., Paule M.G. The effects of chronic cocaine exposure during pregnancy on the acquisition of operant behaviors by rhesus monkey offspring. Neurotoxicol. Teratol. 18:1996;155-166.
34. Murphy E.H., Hammer J.G., Schumann M.D., Groce M.Y., Wang X.H., Jones L., Romano A.G., Harvey J.A. The rabbit as a model for studies of cocaine exposure in utero. Lab. Anim. Sci. 45:1995;163-168.
35. Neerhof M.G., MacGregor S.N., Retzky S.S., Sullivan T.P. Cocaine abuse during pregnancy: Peripartum prevalence and perinatal outcome. Am. J. Obstet. Gynecol. 161:1989;633-638.
36. Phibbs C.S., Bateman D.A., Schwartz R.M. The neonatal costs of maternal cocaine use. JAMA, J. Am. Med. Assoc. 266:1991;1521-1526.
37. Shannon M., Lacouture P.G., Roa J., Wolfe A. Cocaine exposure among children seen at a pediatric hospital. Pediatrics. 83:1989;337-342.
38. Spear L.P., Frambes N.A., Kirstein C.L. Fetal and maternal brain and plasma levels of cocaine and benzoylecognine following chronic subcutaneous administration of cocaine during gestation in rats. Psychopharmacology. 97:1989;427-431.
39. Streissguth A.P., Aase J.M., Clarren S.K., Randels S.P., LaDue R.A., Smith D.F. Cocaine and the use of alcohol and other drugs during pregnancy. Am. J. Obstet. Gynecol. 164:1991;1239-1243.
40. Substance Abuse and Mental Health Services Administration (SAMHSA), USPHS, Preliminary estimates from the 1992 National Household Survey on Drug Abuse: Advanced Report Number 3, National Clearinghouse on Alcohol and Drug Information, Rockville, MD, 1993.
41. Tonkiss J., Shultz P.L., Shumsky J.S., Blease S.J., Kemper T.L., Galler J.R. The effects of cocaine exposure prior to and during pregnancy in rats fed low or adequate protein diets. Neurotoxicol. Teratol. 17:1995;593-600.
42. Weese-Mayer D.E., Klemka-Walden L.M., Chan M.K., Gingras J.L. Effects of prenatal cocaine exposure on perinatal morbidity and postnatal growth in the rabbit. Dev. Pharmacol. Ther. 16:1991;221-230.
43. Wiggins R.C., Ruiz B. Development under the influence of cocaine: I. A comparison of the effects of daily cocaine treatment and resultant undernutrition on pregnancy and early growth in a large population of rats. Metab. Brain Dis. 5:1990;85-99.
44. Wilson M.E., Gordon T.P., Rudman C.G., Tanner J.M. Effects of a natural versus artificial environment on the tempo of maturation in female rhesus monkeys. Endocrinology. 123:1988;2653-2661.
45. Wynne R.M. Morphology of the placenta. Assali N.S. Biology of Gestation. The Maternal Organism. vol. 1:1968;93-182 Academic Press, New York.